Skip to main content

Advertisement

Table 1 Descriptive clinicopathological characteristics of non-muscle invasive bladder cancer patients treated with TURB and RERBT

From: Retrograde en bloc resection for non-muscle invasive bladder tumor can reduce the risk of seeding cancer cells into the peripheral circulation

CharacteristicsTURB, n (%)
N = 9
RERBT, n (%)
N = 12
Totalp value
Age (year)   0.670
< 604 (44.4)7 (58.3)11 
≥ 605 (55.6)5 (41.7)10 
Gender   1.000
Male7 (77.8)9 (75.0)16 
Female2 (22.2)3 (25.0)5 
Smoking history   0.660
No3 (33.3)6 (50.0)9 
Yes6 (66.7)6 (50.0)12 
Pathologic stage   0.660
pTa6 (66.7)6 (50.0)12 
pT13 (33.3)6 (50.0)9 
Size (mean, cm)1.59 ± 0.681.88 ± 0.59210.301
Grade (WHO 2014)   1.000
LG7 (77.8)10 (83.3)17 
HG2 (22.2)2 (16.7)4 
Operation duration (min)   1.000
< 606 (66.7)7 (58.3)13 
≥ 603 (33.3)5 (41.7)8 
Operation duration (mean, min)45.44 ± 15.1447.83 ± 14.90210.722
Total9 (42.9)12 (57.1)21 
  1. TURB transurethral resection of the bladder, RERBT retrograde en bloc TURB, LG low grade, HG high grade